ZA976593B - Novel treatment - Google Patents

Novel treatment

Info

Publication number: ZA976593B
Authority: ZA; South Africa
Prior art keywords: novel treatment; novel; treatment
Prior art date: 1996-07-26

Application number

ZA976593A

Inventor

Thomas Paul Blackburn

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-26

Filing date

1997-07-24

Publication date

1999-01-25

1997-07-24 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

1999-01-25 Publication of ZA976593B publication Critical patent/ZA976593B/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ZA976593A 1996-07-26 1997-07-24 Novel treatment ZA976593B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9615767.2A GB9615767D0 (en)	1996-07-26	1996-07-26	Novel treatment

Publications (1)

Publication Number	Publication Date
ZA976593B true ZA976593B (en)	1999-01-25

Family

ID=10797573

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA976593A ZA976593B (en)	1996-07-26	1997-07-24	Novel treatment

Country Status (19)

Country	Link
EP (1)	EP0936924A2 (en)
JP (1)	JP2000516924A (en)
KR (1)	KR20000029564A (en)
CN (1)	CN1230894A (en)
AR (1)	AR008083A1 (en)
AU (1)	AU725817B2 (en)
BR (1)	BR9710568A (en)
CA (1)	CA2261813A1 (en)
CO (1)	CO5031292A1 (en)
CZ (1)	CZ23799A3 (en)
GB (1)	GB9615767D0 (en)
HU (1)	HUP9903619A3 (en)
IL (1)	IL128219A0 (en)
NO (1)	NO990322L (en)
NZ (1)	NZ333813A (en)
PL (1)	PL331426A1 (en)
TR (1)	TR199900140T2 (en)
WO (1)	WO1998004289A2 (en)
ZA (1)	ZA976593B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9612883D0 (en) *	1996-06-20	1996-08-21	Smithkline Beecham Plc	Novel compounds
WO2000030649A1 (en) *	1998-11-23	2000-06-02	Sepracor Inc.	Pharmaceutical compositions containing olanzapine-n-oxide
US6174882B1 (en)	1998-11-23	2001-01-16	Sepracor Inc.	2-hydroxymethylolanzapine compositions and methods
JP2002530341A (en)	1998-11-23	2002-09-17	セプラコール，インク．	Desmethylolanzapine compositions and methods
CA2366838A1 (en)	1999-03-18	2000-09-21	Gina Guadagno	A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
CA2363784A1 (en) *	1999-05-19	2000-11-30	Astrazeneca Ab	Method of treatment
WO2005013969A1 (en) *	2003-07-15	2005-02-17	Janssen Pharmaceutica N.V.	Antipsychotic agent with socializing properties

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9500998D0 (en) *	1995-03-19	1995-03-19	Haakan Wilhelm Wikstroem	New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics

1996
- 1996-07-26 GB GBGB9615767.2A patent/GB9615767D0/en active Pending
1997
- 1997-07-22 EP EP97918947A patent/EP0936924A2/en not_active Ceased
- 1997-07-22 JP JP10508522A patent/JP2000516924A/en active Pending
- 1997-07-22 CA CA002261813A patent/CA2261813A1/en not_active Abandoned
- 1997-07-22 BR BR9710568A patent/BR9710568A/en not_active Application Discontinuation
- 1997-07-22 CZ CZ99237A patent/CZ23799A3/en unknown
- 1997-07-22 AU AU42972/97A patent/AU725817B2/en not_active Ceased
- 1997-07-22 TR TR1999/00140T patent/TR199900140T2/en unknown
- 1997-07-22 IL IL12821997A patent/IL128219A0/en unknown
- 1997-07-22 NZ NZ333813A patent/NZ333813A/en unknown
- 1997-07-22 HU HU9903619A patent/HUP9903619A3/en unknown
- 1997-07-22 KR KR1019997000622A patent/KR20000029564A/en not_active Application Discontinuation
- 1997-07-22 CN CN97197977A patent/CN1230894A/en active Pending
- 1997-07-22 PL PL97331426A patent/PL331426A1/en unknown
- 1997-07-22 WO PCT/EP1997/004159 patent/WO1998004289A2/en not_active Application Discontinuation
- 1997-07-24 ZA ZA976593A patent/ZA976593B/en unknown
- 1997-07-24 AR ARP970103348A patent/AR008083A1/en not_active Application Discontinuation
- 1997-07-25 CO CO97042582A patent/CO5031292A1/en unknown
1999
- 1999-01-25 NO NO990322A patent/NO990322L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO1998004289A2 (en)	1998-02-05
EP0936924A2 (en)	1999-08-25
AU4297297A (en)	1998-02-20
HUP9903619A3 (en)	2001-03-28
TR199900140T2 (en)	1999-03-22
HUP9903619A2 (en)	2000-10-28
CA2261813A1 (en)	1998-02-05
WO1998004289A3 (en)	1998-03-19
GB9615767D0 (en)	1996-09-04
NZ333813A (en)	2000-07-28
NO990322D0 (en)	1999-01-25
CZ23799A3 (en)	1999-06-16
NO990322L (en)	1999-03-24
KR20000029564A (en)	2000-05-25
IL128219A0 (en)	1999-11-30
AU725817B2 (en)	2000-10-19
CN1230894A (en)	1999-10-06
AR008083A1 (en)	1999-12-09
CO5031292A1 (en)	2001-04-27
PL331426A1 (en)	1999-07-19
BR9710568A (en)	1999-08-17
JP2000516924A (en)	2000-12-19

Publication	Publication Date	Title
GB9411080D0 (en)	1994-07-20	Treatment
GB9700899D0 (en)	1997-03-05	Novel treatment
GB9519033D0 (en)	1995-11-15	Treatment
ZA978359B (en)	1999-03-17	Novel treatment
GB9410512D0 (en)	1994-07-13	Novel treatment
GB9615767D0 (en)	1996-09-04	Novel treatment
GB9411635D0 (en)	1994-08-03	Novel treatment
GB9608657D0 (en)	1996-07-03	Novel treatment
GB2355006B (en)	2001-07-04	Materials treatment
GB9625795D0 (en)	1997-01-29	Novel treatment
GB9612752D0 (en)	1996-08-21	Novel treatment
GB9620085D0 (en)	1996-11-13	Cosmetic treatment
GB9721692D0 (en)	1997-12-10	Novel treatment
GB9616410D0 (en)	1996-09-25	Novel treatment
GB9604046D0 (en)	1996-04-24	Novel treatment
GB9614751D0 (en)	1996-09-04	Novel treatment
GB9616409D0 (en)	1996-09-25	Novel treatment
GB9625201D0 (en)	1997-01-22	Novel treatment
GB9616413D0 (en)	1996-09-25	Novel treatment
GB9616415D0 (en)	1996-09-25	Novel treatment
GB9616412D0 (en)	1996-09-25	Novel treatment
GB9616407D0 (en)	1996-09-25	Novel treatment
GB9619073D0 (en)	1996-10-23	Novel treatment
GB9619493D0 (en)	1996-10-30	Novel treatment
GB9616414D0 (en)	1996-09-25	Novel treatment